To hear Shire tell it, there aren't many adequate and well-controlled drug studies in preschool-aged children with ADHD. But never fear, the company says: It's agreed to a written request by the FDA to investigate its ADHD drug Vyvanse in children aged 4 to 5, with a potential 6-month exclusivity boost for the drug on the line.
As the number of mobile medical apps grows at a steady clip, companies are looking for innovative ways to streamline their products and reach consumers in their element. A new iOS device brings laboratory testing to the home, allowing individuals to test their vital levels with simple swabs of bodily fluids.
In an important step toward the creation of a vaccine against deadly coronaviruses, researchers from Purdue University have figured out how to disable a key enzyme of the SARS virus that helps it hide from the immune system.
The FDA has approved Covidien's new microcatheter, which the Ireland-based company says is the first detachable-tip device of its kind available in the U.S.
The market for deep brain stimulation to treat Parkinson's is heating up. Boston Scientific said its Vercise device is performed well in clinical trials.
Breakout Labs, a science investing venture from PayPal billionaire Peter Thiel, is staking three biotechs at work on early-stage therapies for Alzheimer's disease, gastrointestinal disorders and bone surgery.
Avanir Pharmaceuticals touted positive results from a Phase III trial of its AVP-825 sumatripan intranasal powder for migraines as compared with an oral formulation of the same treatment.
Mobile medical apps are quickly gaining ground as viable therapeutic tools, and a Massachusetts startup is using technology to create an iOS app that helps children with autism read emotions.
Billionaire Patrick Soon-Shiong is working to marry Big Data and cancer treatment, and his old friends at Celgene have again stepped in to help out, investing $25 million in NantHealth, a cloud-based oncology brain trust.
By encasing regenerative stems cells in a hydrophilic polymer, researchers at the University of Rochester were able to prevent them from leaving the repair site early, thereby speeding up the healing process.